Drug Profile
AP 5280
Alternative Names: AP 5070; AP5280; Polymer PlatinateLatest Information Update: 23 Sep 2021
Price :
$50
*
At a glance
- Originator University of London School of Pharmacy
- Developer Access Pharmaceuticals
- Class Antineoplastics; Platinum complexes
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Ovarian cancer